Capital Asset Advisory Services’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-21,745
Closed -$336K 711
2021
Q2
$336K Sell
21,745
-9,925
-31% -$167K 0.04% 342
2021
Q1
$640K Buy
31,670
+5,763
+22% +$143K 0.1% 198
2020
Q4
$701K Buy
25,907
+4,619
+22% +$104K 0.12% 140
2020
Q3
$394K Sell
21,288
-942
-4% -$16.7K 0.08% 201
2020
Q2
$383K Sell
22,230
-681
-3% -$10.4K 0.08% 214
2020
Q1
$314K Buy
22,911
+3,536
+18% +$52.7K 0.08% 212
2019
Q4
$343K Buy
+19,375
New +$259K 0.08% 241

Other funds holding CLLS

Capital Asset Advisory Services's CLLS Position: Q3 2021 in Review

Capital Asset Advisory Services sold out of Cellectis (CLLS) in Q3 2021, closing a stake of 21,745 shares — an estimated $336K sold.

Capital Asset Advisory Services first reported a position in CLLS in Q4 2019 and held it in 7 quarters. The position peaked at $701K in Q4 2020. 70 funds tracked by Wall St. Rank hold CLLS as of Q3 2021.

  • Capital Asset Advisory Services reported no remaining Cellectis position as of Q3 2021 after selling out during the quarter.
  • Capital Asset Advisory Services sold 21,745 Cellectis shares in Q3 2021, an estimated $336K.
  • Capital Asset Advisory Services first reported a position in Cellectis in Q4 2019 and held it in 7 quarters.
  • Capital Asset Advisory Services's Cellectis position peaked at $701K in Q4 2020.
  • 70 funds tracked by Wall St. Rank held Cellectis as of Q3 2021.

Based on Capital Asset Advisory Services's 13F filing for Q3 2021, filed 14 Oct 2021.